Monoclonal antibody RM2 as a potential ligand for a new immunotracer for prostate cancer imaging

Abstract Objectives To investigate the potential of monoclonal antibody (mAb) RM2 as a ligand for a radioimmunotracer for prostate cancer imaging. Methods Labeling was conducted with mAb RM2 and125 I using the chloramine-T method. The cell study was conducted with PC-3 and LNCaP, which are prostate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Nuclear medicine and biology 2012-10, Vol.39 (7), p.944-947
Hauptverfasser:	Hasegawa, Yoko, Oyama, Nobuyuki, Nagase, Keiko, Fujibayashi, Yasuhisa, Furukawa, Takako, Murayama, Yasuko, Arai, Yoichi, Saito, Seiichi, Welch, Michael J, Yokoyama, Osamu
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacokinetics Biological and medical sciences Carbohydrate Sequence Cell Line, Tumor Gangliosides - chemistry Gangliosides - immunology Gynecology. Andrology. Obstetrics Humans IgM Immunoconjugates - immunology Immunoconjugates - pharmacokinetics Iodine Radioisotopes Ligands Male Male genital diseases Medical sciences Mice Molecular Sequence Data Monoclonal antibody Nephrology. Urinary tract diseases Prostate cancer Prostatic Neoplasms - diagnosis Radioactive Tracers Radioimmunoligand Radiology RM2 Tumors Tumors of the urinary system Urinary tract. Prostate gland
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!